One Drug for All RNA Viruses

by

Live Poster Session: Zoom Link
Thursday, July 30th 1:15-2:30pm EDT

Mohammed Ullah
Mohammed Ullah

I am representing Brooklyn, NY, flatbush squad. Rising junior with the hopes of working in industry to somehow better the world by creating cost-effective drugs, or treatments. Medicine should be universal and should not be exploited by big pharma companies. This research project was inspired by Professor Gupta and Professor Taylor. Hope you enjoy what I learned and put together!!!

Abstract: With cases and deaths constantly rising, and a vaccine that has yet to been developed, scientists everywhere are focusing their efforts on repurposed drugs, preexisting FDA approved drugs used to treat other viruses/illnesses, to see which ones are safely effective at treating Covid-19 patients with symptoms from mild to acute pneumonia to severe lung failure, which can lead to death. Dozens of pharma companies and scientists around the world have performed molecular docking techniques, in vitro/vivo experiments, and clinical trials to discover the prophylactic effects of repurposed drugs. Based on the CDCN Corona Registry, which consists of dozens of therapeutic agents used on COVID-19 patients, and the relevancy of specific drugs mentioned in recent media, Hydroxychloroquine/chloroquine (HCQ/CQ), Interferon α/b (IFN-α/b), Lopinavir/Ritonavir (LPV/RTV), Ribavirin, and Remdesivir (RDV) will be the drugs researched more thoroughly in this project. The objective (Aim 1) of this poster is to determine if there are any homologs between SARS-CoV-2 and the viruses that each of the 4 therapeutic agent treatments were originally intended to treat.

Research-Poster-2020-Ullah

Live Poster Session: Zoom Link
Thursday, July 30th 1:15-2:30pm EDT

Leave a Comment